Beyond the Virtual Screening Paradigm: Structure-Based Searching for New Lead Compounds

被引:27
|
作者
Schlosser, Jochen [1 ]
Rarey, Matthias [1 ]
机构
[1] Univ Hamburg, Ctr Bioinformat, Res Grp Computat Mol Design, D-20146 Hamburg, Germany
关键词
INCREMENTAL CONSTRUCTION ALGORITHM; PROTEIN-LIGAND DOCKING; MOLECULAR DOCKING; GENETIC ALGORITHM; AUTOMATED DOCKING; FLEXIBLE DOCKING; DRUG DISCOVERY; DESIGN; FLEXIBILITY; PERSPECTIVE;
D O I
10.1021/ci9000212
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The standard approach to structure-based high-throughput virtual screening is a sequential procedure: Each molecule of a given library is screened against the target protein, eventually generating a ranked list of molecules. In this paper a new paradigm avoiding the sequential screening pipeline is presented. Based on a novel descriptor, compounds can be directly accessed by their chemical and shape complementarity to a given protein active site. The docking calculation is performed inherently during the search process since each search result automatically implies a ligand pose in the active site. The new method named TRIXX BMI is ideally suited for application scenarios in which medicinal chemists request a certain pharmacophore interaction pattern to a protein. By using an innovative indexing technology, sublinear runtimes in the number of ligands can be achieved. Redocking experiments show that TRIXX BMI correctly predicts the pose of the bioactive conformation within an rmsd of less than 2.0 angstrom of the cocrystallized ligand in 80% of 85 protein-ligand complexes of the Astex Diverse Set. In addition to that several comparative enrichment experiments show that TRIXX BMI is on a competitive basis to established virtual screening technology, while the observed runtimes are clearly below one second per compound.
引用
收藏
页码:800 / 809
页数:10
相关论文
共 50 条
  • [1] Structure-Based Virtual Screening Identifying Novel FOXM1 Inhibitors as the Lead Compounds for Glioblastoma
    Swati, Kumari
    Srivastava, Rashi
    Agrawal, Kirti
    Panda, Siva Prasad
    Prakash, Anand
    Kumar, Dhruv
    Chen, Hailiang
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024,
  • [2] Quantum Chemical Approaches in Structure-Based Virtual Screening and Lead Optimization
    Cavasotto, Claudio N.
    Adler, Natalia S.
    Aucar, Maria G.
    FRONTIERS IN CHEMISTRY, 2018, 6
  • [3] Structure-Based Pharmacophores for Virtual Screening
    Loewer, Martin
    Proschak, Ewgenij
    MOLECULAR INFORMATICS, 2011, 30 (05) : 398 - 404
  • [4] Structure-based virtual screening: an overview
    Lyne, PD
    DRUG DISCOVERY TODAY, 2002, 7 (20) : 1047 - 1055
  • [5] Structure-based virtual ligand screening
    Villoutreix, Bruno O.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2006, 7 (05) : 367 - 367
  • [6] Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer
    Zhou, Zi-Ying
    Han, Xiao-Yang
    Sun, Lian-Qi
    Li, Si-Yan
    Xue, Si-Tu
    Li, Zhuo-Rong
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [7] From screening to searching: an index-driven approach to structure-based lead identification
    J Schlosser
    M Rarey
    Chemistry Central Journal, 3 (Suppl 1)
  • [8] Lead finding using structure-based virtual screening: Application to aldose reductase
    Hoffmann, RD
    Bertrand, HO
    Langer, T
    RATIONAL APPROACHES TO DRUG DESIGN, 2001, : 418 - 422
  • [9] Structure-Based Virtual Screening of Antiviral Compounds Targeting the Norovirus RdRp Protein
    Alqahtani, Leena S.
    Alkathiri, Ahmad Salah
    Alzahrani, Abdulrahman
    Alghamdi, Rashed Mohammed
    Alamri, Waad Abdulrahmman
    Kamal, Mohammad Azhar
    Aloufi, Ahmed Hamdan
    Alamri, Ali Saeed
    Alam, Qamre
    ADVANCEMENTS IN LIFE SCIENCES, 2024, 11 (02): : 488 - 492
  • [10] Analysis of structure-based virtual screening studies and characterization of identified active compounds
    Ripphausen, Peter
    Stumpfe, Dagmar
    Bajorath, Juergen
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (05) : 603 - 613